carbitol has been researched along with carvedilol in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nie, S; Pan, W; Sun, P; Wei, L | 1 |
| Bendas, ER; Mahmoud, EA; Mohamed, MI | 1 |
| Bandyopadhyay, S; Kapil, R; Katare, OO; Khurana, L; Singh, B | 1 |
| Abdallah, MH; El-Megrab, NA; El-Nahas, HM; Ibrahim, TM | 2 |
5 other study(ies) available for carbitol and carvedilol
| Article | Year |
|---|---|
Preparation and evaluation of SEDDS and SMEDDS containing carvedilol.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Benzoic Acid; Biological Availability; Carbazoles; Carvedilol; Chemistry, Pharmaceutical; Dogs; Drug Compounding; Drug Delivery Systems; Emulsions; Ethylene Glycols; Particle Size; Polysorbates; Propanolamines; Solubility; Solvents; Surface-Active Agents | 2005 |
Preparation and evaluation of self-nanoemulsifying tablets of carvedilol.
Topics: Adrenergic beta-Antagonists; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carbazoles; Carvedilol; Castor Oil; Cell Proliferation; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Emulsions; Ethylene Glycols; Excipients; HCT116 Cells; Humans; Inhibitory Concentration 50; Kinetics; Nanoparticles; Paclitaxel; Powders; Propanolamines; Silicon Dioxide; Solubility; Tablets; Technology, Pharmaceutical; Triglycerides | 2009 |
Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential.
Topics: Animals; Biological Availability; Caprylates; Carbazoles; Cardiovascular Agents; Carvedilol; Chemistry, Pharmaceutical; Drug Delivery Systems; Drug Stability; Emulsions; Ethylene Glycols; Excipients; Glycerides; Glycerol; Intestinal Absorption; Jejunum; Male; Microscopy, Electron, Transmission; Nanostructures; Oils; Particle Size; Perfusion; Propanolamines; Rats; Rats, Wistar; Solubility | 2011 |
Upgrading of dissolution and anti-hypertensive effect of Carvedilol via two combined approaches: self-emulsification and liquisolid techniques.
Topics: Animals; Antihypertensive Agents; Carbazoles; Carvedilol; Chemistry, Pharmaceutical; Drug Delivery Systems; Emulsions; Ethylene Glycols; Excipients; Polymers; Polysorbates; Propanolamines; Propylene Glycols; Rats; Solubility; Surface-Active Agents; Tablets | 2018 |
Transdermal ethosomal gel nanocarriers; a promising strategy for enhancement of anti-hypertensive effect of carvedilol.
Topics: Administration, Cutaneous; Animals; Antihypertensive Agents; Carvedilol; Cholesterol; Ethanol; Ethylene Glycols; Gels; Male; Nanocapsules; Permeability; Rabbits; Rats; Skin Absorption; Solubility; Viscosity | 2019 |